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Pancreatic ductal adenocarcinomas 
(PDACs) are characterized by a dense 
desmoplastic reaction, primarily reflect-
ing the activation of pancreatic stellate 
cells (PSC) driven by cancer cells.1 Non-
transformed, healthy pancreatic tissues 
contain low amounts of PSCs in a quies-
cent state. In this setting, PSCs contain 
vitamin A droplets and have a limited 
ability to proliferate, migrate, and secrete 
extracellular matrix proteins.1,2 As a result 
of tissue injury, PSCs become activated 
in response to growth factors, oxidative 
stress, and change in tissue plasticity. 
Such activated PSCs lose their cytoplas-
mic vitamin A droplets, adopt a myo-
fibroblastic phenotype, produce large 
amounts of extracellular matrix proteins, 
and exhibit increased migratory and pro-
liferative activity. In these conditions, 
PSCs not only stimulate the prolifera-
tion of pancreatic cancer cells and their 
invasive potential, but also inhibit their 
apoptotic demise through a multitude of 
signaling pathways.2
The activation of PSCs is revers-
ible, even in presence of malig-
nant cells, and hence potentially 
important from a therapeutic standpoint.3 
LSL-KrasG12D/+-LSL-Trp53R172H/+-Pdx-
1-cre (KPC) mice provide a spontane-
ous model of PDAC that mimics several 
features of the human disease, including 
the representative desmoplastic stroma.4 
When KPC mice were treated with all-
trans retinoic acid (ATRA), the desmo-
plastic stroma collapsed along with the 
inhibition of tumor growth3.ATRA effi-
ciently restores retinol depots within PSCs 
in vivo, rendering them quiescent.
The failure of many chemotherapeu-
tics to provide benefits to pancreatic can-
cer patients despite their efficacy against 
epithelial cancer cells in vitro has been 
attributed to the fact that many research-
ers have failed to recognize the protec-
tive effects of the desmoplastic stroma.5 
This dense stroma is being recognized 
to comprise distinct morphological and 
functional compartments, as evidenced by 
independent work from different labora-
tories.6,7 For example, the gene expression 
pattern of stromal components has been 
show to differ depending on their proxim-
ity to malignant cells. In particular, the 
juxtatumoral stroma (the stromal compo-
nent that is juxtaposed to malignant cells) 
exhibits a distinct gene expression profiles 
as compared with other stromal compart-
ments (panstroma).6
In the setting of inflammation and 
fibrosis, hepatic stellate cells (HSCs) have 
been shown to act as antigen-presenting 
cells and interact with CD1- as well as 
MHC class I- and MHC class II-restricted 
T cells.8 Thus, HSCs can present lipid 
antigens to natural killer (NK) cells, stim-
ulating their proliferation, as well as anti-
genic peptides to CD8+ and CD4+ T cells, 
resulting in the cross-priming of the for-
mer. However, to date no such interac-
tion has been reported between PSCs and 
T cells.
Most often, the infiltration of neo-
plastic lesions by CD8+ T lymphocytes is 
associated with improved prognosis.7 We 
have recently investigated the global and 
compartment-specific immune infiltrate 
of human pancreatic cancer, as compared 
with other pancreatic disorders, using an 
unbiased automated system. We unveiled 
for the first time a PDAC-specific and 
compartment-specific immune cell infil-
trative defect. In particular, neoplastic 
tissues, in particular those associated with 
poor prognosis (i.e., from cases of PDAC 
and cholangiocarcinoma), were infiltrated 
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a detailed map demonstrating the spatially restricted distribution of immune cells within the desmoplastic stroma 
of human pancreatic tumors opens up the field of pancreatic oncoimmunology. CD8+ T cells located in the proximity of 
malignant lesions are associated with a survival advantage, suggesting the existence of immunoediting. Pancreatic stel-
late cells appear to dictate the infiltration of the juxtatumoral stroma by CD8+ T cells.
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by immune cells of all types, with the 
standalone exception of CD8+ cytotoxic 
T cells, to greater extents than benign tis-
sues. Indeed, CD8+ T cells were found 
to infiltrate PDAC lesions in amounts 
that were comparable to those observed 
in chronic pancreatitis but significantly 
lower than those detected in other malig-
nant pancreatico-biliary (PB) conditions. 
Similar findings have been obtained with 
KPC mice.9
The most intriguing of our findings 
was that we observed a stromal compart-
ment-specific, as opposed to generalized, 
infiltrative defect. In particular, we 
found that CD8+ T cells, CD20+ B cells, 
CD56+ NK cells, and FOXP3+ regula-
tory T cells (T cells) are unable to suffi-
ciently infiltrate the juxtatumoral stroma 
of PDAC lesions (Fig. 1). Conversely, 
other cells of the innate immune system 
such as CD68+ macrophages and myelo-
peroxidase-expressing neutrophils could 
infiltrate this compartment. Of note, 
PDAC patients harboring high amounts 
of CD8+ T cells in the juxtatumoral 
stroma exhibited improved survival. We 
could recapitulate most of these findings 
in KPC mice. Upon the administration 
of ATRA to KPC mice (resulting in the 
quiescence of PSCs), we observed a rever-
sal of the juxtatumoral exclusion of CD8+ 
T cells. Conversely, no difference in the 
distribution of other immune cell subsets 
was detected in response to ATRA. These 
observations suggest that activated PSCs 
in the panstroma selectively sequester 
immune cells. These findings fit nicely 
with the results obtained by Winau 
et al. relative to the interplay between 
CD8+ T cells, NK cells and HSCs in the 
course of hepatic inflammation. While 
we did not exhaustively investigate all 
the functional interactions between 
PSCs and immune cells including NK 
cells, MDSCs (myeloid-derived suppres-
sor cells) and others, our findings pro-
vide a vivid picture of the human PDAC 
microenvironment for other researchers 
to build their hypotheses and investigate 
such a complex crosstalk.
Our initial migration and adhe-
sion experiments based on T cells and 
PSCs isolated from healthy individu-
als and PDAC patients confirmed the 
critical role of the activation state of 
PSC in altering the behavior of T cells. 
Chemokine C-X-C motif ligand 12 
(CXCL12) was identified from our pre-
vious work as a potential inducer of such 
a functional alteration.8 Using recom-
binant CXCL12 and RNA interference 
we could demonstrate that, at least in this 
setting, the migration of T cells depend 
on CXCL12 secreted from PSCs, which 
may explain the in vivo sequestration that 
we observed. A number of other adhe-
sion molecules and chemokines should be 
investigated for their ability to influence 
Figure  1. Influence of aTra on the immune cell subsets that infiltrate the stroma of pancreatic 
tumors. (A) The pancreatic ductal adenocarcinoma (PDaC) lesions developing in LSL-KrasG12D/+-LSL-
Trp53R172H/+-Pdx-1-cre (KPC) mice exhibit the same pattern of infiltration by immune cells observed in 
human PDaC tissues. In particular, the distribution of neutrophils and macrophages is homogeneous 
throughout the stromal compartments, while regulatory T cells (Tregs), cytotoxic CD8+ T cells and B 
cells are enriched in the panstromal compartment compared with the juxtatumoral stroma. (B) The 
administration of all-trans retinoic acid (aTra) to these mice induces the quiescence of pancreatic 
stellate cell, resulting in an increased proportion of cytotoxic T cells within the juxtatumoral stroma.
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the spatial and temporal distribution of 
immune cells within PDAC lesions.
Altogether, our findings demonstrate 
that activated PSCs within the PDAC 
stroma have an important impact on the 
migration of immune cells toward malig-
nant lesions, perhaps orchestrating a hier-
archy of interactions between immune cells 
and neoplastic cells. We have shown that 
CD8+ T lymphocytes found in the prox-
imity of malignant cells confer a survival 
benefit to PDAC patients, and that their 
abundance can be increased by ATRA, 
owing to its ability to disrupt the juxtatu-
moral stroma. Thus, PSCs play an impor-
tant role in the modulation of the crosstalk 
between neoplastic, stromal and immune 
cells, and need therefore to be considered as 
a therapeutic target in the context of com-
binatorial anticancer regimens.
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